logo
National Building raises subsidiary's capital to SAR 300M

National Building raises subsidiary's capital to SAR 300M

Argaam4 days ago
National Building and Marketing Co. (NBM) increased the capital of its subsidiary, Ajeej Steel Manufacturing Co. (a closed joint stock company), from SAR 180 million to SAR 300 million.
In a statement to Tadawul, NBM said the subsidiary's share capital will be raised from 180 million to 300 million ordinary shares under this transaction.
The SAR 120 million capital increase was covered from the shareholders' current account, it added.
This step is a part of supporting the growth and expansion plans of its subsidiary, which will strengthen NBM's financial position and positively reflect on its consolidated results.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Signworld issues prospectus to float 1.5M shares on Nomu
Signworld issues prospectus to float 1.5M shares on Nomu

Argaam

timean hour ago

  • Argaam

Signworld issues prospectus to float 1.5M shares on Nomu

National Signage Industrial Co. (Signworld) issued today, July 27, the prospectus to float 1.5 million shares, or 20% of capital, on the Nomu -Parallel Market. The company will offer 1.5 million shares, equal to 25% of pre-offering and 20% of post-offering capital, to qualified investors. For More IPOs The share sale will run from Aug. 17-24. The Capital Market Authority (CMA) approved, in March, the company's application for direct listing on Nomu. Signworld's core business involves the design, manufacturing, and assembly of electronic panels and displays for various applications, in addition to installation and maintenance services. It operates through three branches. Company Profile Company National Signage Industrial Co. (Signworld) Core Activities Manufacturing and sale of feed products Market Nomu-Parallel Market Pre-IPO Capital SAR 60mln Number of Shares 6 mln Post-IPO Capital SAR 75 mln New Number of Shares 7.5 mln Nominal Value SAR 10 a share IPO Summary Issue Percentage 20% of post-IPO capital, 25% of pre-IPO capital Offered Shares SAR 1.5 mln IPO Minimum Limit 10 shares IPO Maximum Limit 374,990 shares Offer Period Aug. 17-24, 2025 Final Allocation Aug. 27, 2025 Surplus Refund (If any) Aug. 31, 2025 Company Shareholders Shareholders Before IPO After IPO Number of Shares (mln) Ownership (%) Number of Shares (mln) Ownership (%) Al Mohandes Holding Group 6.00 100.00 % 6.00 80% Qualified investors -- -- 1.50 20% Total 6.00 100 % 7.50 100%

NADEC CEO says dividend policy tied to strategy, operations
NADEC CEO says dividend policy tied to strategy, operations

Argaam

time2 hours ago

  • Argaam

NADEC CEO says dividend policy tied to strategy, operations

Solaiman Altwaijri, CEO of National Agricultural Development Co. (NADEC), said the cash dividend decision depends on several strategic and operational factors, mainly the company's current stage and future funding requirements. He explained in an interview with Argaam that since NADEC is undergoing an expansion phase, financial resources are currently directed toward executing its growth plans. Altwaijri added that the company's outlook for the remainder of 2025 remains aligned with its strategic and operational roadmap and that no major developments are anticipated. He said Q2 2025 net profit rose on the back of a 5.1% year-on-year (YoY) increase in net revenue, driven by growth in new business segments, and although operating costs rose due to higher fuel expenses, this was offset by a 23% YoY increase in treasury income. Commenting on the protein segment, Altwaijri stated that the red meat business, a recent addition, generated SAR 59 million in net revenue during Q2, marking a 35% YoY growth, while profitability indicators remained stable. He noted that the dairy and food segment remained the top revenue contributor at 89%, followed by the protein segment at 7% and agriculture at 4%. Altwaijri also pointed out that the Central and Eastern Provinces recorded the strongest demand during Q2, with both seeing significant sales growth.

SPIMACO launches oncology, high-potent drug plant
SPIMACO launches oncology, high-potent drug plant

Argaam

time2 hours ago

  • Argaam

SPIMACO launches oncology, high-potent drug plant

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) inaugurated its oncology and high potent drugs plant at a total value of SAR 272 million. In a statement to Tadawul today, July 27, SPIMACO said the plant boasts an annual production capacity exceeding 275 million therapeutic units. Incorporating the latest technologies, the new facility adopts the highest international standards in pharmaceutical manufacturing, ensuring operational efficiency, personnel safety, and environmental sustainability. As all technical, regulatory, and operational requirements were completed, the plant will produce the first commercial batches this month, SPIMACO stated.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store